ISPC
iSpecimen
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 1
Sell signal 1
EPS Beats Expectation
Revenue Below Expectations
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About ISPC
Ispecimen Inc.
An online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers
8 Cabot Road, Woburn, Massachusetts 02420
--
ISpecimen Inc., was incorporated in 2009 under the laws of the State of Delaware. The company has developed and launched a proprietary online market platform that connects researchers with subjects, specimens and related data. ISpecimen is a technology-driven company founded to solve a key challenge: how to connect life science researchers who need human biofluids, tissues and living cells (" biological samples ") to the billions of biological samples provided by medical institutions around the world (but not easily available). The company's groundbreaking iSpecimen Marketplace platform aims to address this issue and transform the biological sample procurement process to accelerate medical discovery.
Company Financials
EPS
ISPC has released its 2024 Q2 earnings. EPS was reported at -0.19, versus the expected -0.28, beating expectations. The chart below visualizes how ISPC has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ISPC has released its 2024 Q4 earnings report, with revenue of 1.48M, reflecting a YoY change of -42.70%, and net profit of -6.05M, showing a YoY change of -96.77%. The Sankey diagram below clearly presents ISPC’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
